Join Us: Inhaled & Nasal Biologics | DNA Forum 2025

 

We are delighted to announce that we are hosting the 4th edition of the Annual Inhaled & Nasal Biologics | DNA Forum in September 2025 with the Academy of Pharmaceutical Sciences (APS) as Conference Partner. We invite you to join two days of cutting-edge talks and networking opportunities with leaders in this complex area of drug product and inhaled vaccines development.

 

Biologics and nucleotide-based therapeutics have gained increasing importance in the last decade. Pulmonary and intranasal delivery of these presents a compelling, non-invasive alternative to traditional parenteral methods, offering potential for both local respiratory and systemic treatments across a variety of diseases and indications. However, biologics, mRNA, nucleotide-based therapeutics and vaccines present unique challenges for respiratory administration and whilst there can be many ways to design a product, the developer needs to balance, amongst many other things, product performance, manufacturability, regulatory risk, and commercial elements. 

 

During this 4th edition, the conference will provide a platform for discussing the latest research and optimal strategies for pulmonary and intranasal biologic/DNA drug development. With renowned industry leaders who will share their insight and real-world case studies, our speakers will explore innovative formulation and delivery technologies and the rationale behind overcoming development challenges. Don't miss out on this opportunity to learn more about key topics shaping the future of inhaled therapeutics. 

 

Secure your place today - registration is live >

Meet our esteemed 2025 speakers confirmed so far >

 

Questions?